Vergoeding 2020-2024 voor ATC-subgroep L04AG05 : Vedolizumab
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
|
L04AG05 Vedolizumab
|
42.596.426 | 50.204.262 | 55.427.788 | 63.253.119 | 64.794.761 |
| Totaal | 42.596.426 | 50.204.262 | 55.427.788 | 63.253.119 | 64.794.761 |